Categories: HealthcareNews

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Brandon Rice

NEW YORK–(BUSINESS WIRE)–$PIPRPiper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Brandon Rice as a managing director within the healthcare investment banking group. Rice joins Piper Sandler with 17 years of healthcare investment banking experience in strategic and capital markets transactions across the med-tech sector. Rice will continue to cover the med-tech sector and will be based in the firm’s New York office.


“Brandon brings high-profile relationships and extensive transaction experience in the med-tech sector to our team. The addition of Brandon’s expertise positions us for continued market leadership advising med-tech companies and ensures we continue to deliver best-in-class services to our clients. We are excited to welcome him to the healthcare team,” said J.P. Peltier, global group head of healthcare investment banking.

Prior to joining the firm, Rice spent 17 years at Bank of America Securities, most recently as a managing director in the global healthcare investment banking group. In this role, his primary focus was M&A advisory and capital raising for both public and private disruptive medical technology companies. He began his career at Merrill Lynch in 2006, prior to its merger with Bank of America Securities.

“Piper Sandler has been the trusted partner in medical devices for several decades, with a long history of leadership in M&A and capital raising. I am thrilled to be joining a franchise that shares my deep commitment to entrepreneurs and companies that are driving meaningful innovation and disruption in medical devices and the broader healthcare sector,” said Rice.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Sandler Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2023. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Pamela Steensland

Tel: 612 303-8185

pamela.steensland@psc.com

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

2 hours ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

2 hours ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

2 hours ago